Hostname: page-component-784d4fb959-jtjl6 Total loading time: 0 Render date: 2025-07-15T22:41:26.430Z Has data issue: false hasContentIssue false
  • English
  • Français

Severe Reactions to Fentazin in Mental Deficiency Practice

Published online by Cambridge University Press:  08 February 2018

Peter Sykes
Peter Sykes*
Affiliation:
Ladysbridge Hospital, Banff
Get access Rights & Permissions [Opens in a new window]

Extract

Fentazin—Perphenazine—is a phenothiazine derivative which has gained a considerable amount of popularity with psychiatrists employed in treating severe schizophrenia and chronic psychosis. At present, however, there would appear to be few reports of its use in mental deficiency practice.

Information

Type
Original Articles
Information
Journal of Mental Science , Volume 106 , Issue 445 , October 1960 , pp. 1584 - 1586
Copyright
Copyright © Royal College of Psychiatrists, 1960 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1 Cahn, C. H., and Lehman, H. E., Canad. Psychiat. Ass. J., 1957, 2, 104.Google Scholar
2 Manson Browne, N. L., ibid., 1958, 79, 985.Google Scholar
3 Darling, H. F., “Diseases of the nervous system”, per Pharmacy International, 1959, 13, 34.Google Scholar
4 Forrest, F. M., and Forrest, I. S., Amer. J. Psychiat., 1957, 113, 931.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.